Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage
- PMID: 37943045
- PMCID: PMC10715071
- DOI: 10.1128/spectrum.03146-23
Active surveillance for carbapenem-resistant Acinetobacter baumannii (CRAB) carriage
Abstract
Our study's results provide promising evidence for the incorporation of a high-sensitivity carbapenem-resistant Acinetobacter baumannii (CRAB) screening method in healthcare settings. Such an approach could prove beneficial in enhancing infection prevention and control measures, leading to improved patient outcomes and potentially alleviating the burden of CRAB in healthcare systems.
Keywords: active surveillance; carbapenem-resistant Acinetobacter baumannii (CRAB); pre-moistened sponge; screening; skin sampling.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, Kahlmeter G, Pan A, Petrosillo N, Rodríguez-Baño J, Singh N, Venditti M, Yokoe DS, Cookson B, European Society of Clinical Microbiology . 2014. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant gram-negative bacteria in hospitalized patients. Clin Microbiol Infect 20 Suppl 1:1–55. doi: 10.1111/1469-0691.12427 - DOI - PubMed
-
- World Health Organization . 2017. Guidelines for the prevention and control of carbapenem-resistant enterobacteriaceae, Acinetobacter baumannii and Pseudomonas aeruginosa in health care facilities. Available from: https://iris.who.int/handle/10665/259462 - PubMed
-
- Centers for Disease Control and Prevention . 2022. Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms (MDROs). available from. Available from: https://www.cdc.gov/hai/pdfs/mdro-guides/Health-Response-Contain-MDRO-50...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
